Yahoo! Finance Search - Finance Home - Yahoo! - Help

Friday, November 27 2015 8:50am ET - U.S. Markets open in 40 minutes.
Industry Center - Drug Manufacturers - Major
Industry Center > Drug Manufacturers - Major > News
More On This Industry
· Summary
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
· REIT - Retail
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Drug Manufacturers - Major News
Latest News
Friday, Nov 27, 2015
·1 Dividend Stock to Rule Them All
at Motley Fool - 11 minutes ago
·Bristol-Myers Looks Beyond Cancer To Build Portfolio
at Investor's Business Daily, Inc. - 48 minutes ago
·Novartis’s Cosentyx: Europe’s First IL-17A Inhibitor for Some Uses
- Fri 3:06 am ET
Thursday, Nov 26, 2015
·[$$] Hillary's Pfizer Follies
at The Wall Street Journal Online - Thu 4:57 pm ET
·CheckMate -025 Study Supports Opdivo’s Approval
- Thu 1:58 pm ET
·FDA Approves Opdivo for Additional Indications
- Thu 1:58 pm ET
·Two-decade Pfizer mission pays off for Guggenheim's deal king
Reuters - Thu 1:57 pm ET
·Novartis: Market Responds to European Commission’s Cosentyx Approval
- Thu 10:06 am ET
·Pfizer-Allergan: If Corporate Taxes Cause Inversions Maybe We Should Change Taxes?
at - Thu 9:03 am ET
·Gilead Sciences Grabs 4 Regulatory Wins -- but Does It Matter?
at Motley Fool - Thu 9:03 am ET
·Keytruda: Hope for Merck’s Immuno-Oncology Franchise
- Thu 12:04 am ET
·Remicade: A Falling Drug in Merck’s Immunology Franchise
- Thu 12:04 am ET
Wednesday, Nov 25, 2015
·New medicine for house dust mite allergic rhinitis now available in Japan
GlobeNewswire - Wed 8:06 pm ET
·Pfizer shareholders may have cause for doubts
at - Wed 6:34 pm ET
·Court revives Oregon suit over 'phantom recall' of Motrin
AP - Wed 5:57 pm ET
·Valeant, Glaxo, Novartis Skin Drug Prices Have Soared
at Investor's Business Daily, Inc. - Wed 5:01 pm ET
·Episode 2: Pfizer Sticks It to U.S. Treasury
at Bloomberg - Wed 4:54 pm ET
·Amgen applies to FDA for competitor drug to AbbVie's Humira
at MarketWatch - Wed 4:27 pm ET
·How Johnson & Johnson Spent $71 Billion in 12 Months
at Motley Fool - Wed 4:22 pm ET
·Amgen files for U.S. approval of biosimilar to Humira
Reuters - Wed 4:11 pm ET
More Latest News...

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drug Manufacturers - Major Headlines
More Finance RSS Feeds

Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2015 Morningstar, Inc. All Rights Reserved. Company information © 2015 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2015, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?